Generic dossier

Avibactam + ceftazidime

0.5 g / 2 g · Injection · Antibiotic

Product data

Strength
0.5 g / 2 g
Dosage form
Injection
Dosage-form group
Injectable
Therapeutic area
Antibiotic
Market
RoW
Status
Dossier ready
Development status
Dossier available for RoW markets
Portfolio
Generic dossier

Start a conversation

Where does your programme stand?

Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.

Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23

KMS PharmaChennai